198 related articles for article (PubMed ID: 28533414)
1. Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.
McNally JP; Millen SH; Chaturvedi V; Lakes N; Terrell CE; Elfers EE; Carroll KR; Hogan SP; Andreassen PR; Kanter J; Allen CE; Henry MM; Greenberg JN; Ladisch S; Hermiston ML; Joyce M; Hildeman DA; Katz JD; Jordan MB
Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4782-E4791. PubMed ID: 28533414
[TBL] [Abstract][Full Text] [Related]
2. Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.
Johnson TS; Terrell CE; Millen SH; Katz JD; Hildeman DA; Jordan MB
J Immunol; 2014 Jan; 192(1):84-91. PubMed ID: 24259502
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.
Carr MI; Roderick JE; Zhang H; Woda BA; Kelliher MA; Jones SN
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15024-15029. PubMed ID: 27956626
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
[TBL] [Abstract][Full Text] [Related]
5. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
6. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
von Kutzleben S; Pryce G; Giovannoni G; Baker D
Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
[TBL] [Abstract][Full Text] [Related]
7. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
8. MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.
Tovar C; Graves B; Packman K; Filipovic Z; Higgins B; Xia M; Tardell C; Garrido R; Lee E; Kolinsky K; To KH; Linn M; Podlaski F; Wovkulich P; Vu B; Vassilev LT
Cancer Res; 2013 Apr; 73(8):2587-97. PubMed ID: 23400593
[TBL] [Abstract][Full Text] [Related]
9. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
10. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
McDonald CA; Payne NL; Sun G; Moussa L; Siatskas C; Lim R; Wallace EM; Jenkin G; Bernard CC
J Neuroinflammation; 2015 Jun; 12():112. PubMed ID: 26036872
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
13. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
14. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
Kuchroo VK; Anderson AC; Waldner H; Munder M; Bettelli E; Nicholson LB
Annu Rev Immunol; 2002; 20():101-23. PubMed ID: 11861599
[TBL] [Abstract][Full Text] [Related]
15. Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity.
Gammon JM; Tostanoski LH; Adapa AR; Chiu YC; Jewell CM
J Control Release; 2015 Jul; 210():169-78. PubMed ID: 26002150
[TBL] [Abstract][Full Text] [Related]
16. IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Kavrochorianou N; Evangelidou M; Markogiannaki M; Tovey M; Thyphronitis G; Haralambous S
J Leukoc Biol; 2016 Jan; 99(1):175-88. PubMed ID: 26232452
[TBL] [Abstract][Full Text] [Related]
17. SH2D1A regulates T-dependent humoral autoimmunity.
Hron JD; Caplan L; Gerth AJ; Schwartzberg PL; Peng SL
J Exp Med; 2004 Jul; 200(2):261-6. PubMed ID: 15263031
[TBL] [Abstract][Full Text] [Related]
18. Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint.
Pedraza-Alva G; Koulnis M; Charland C; Thornton T; Clements JL; Schlissel MS; Rincón M
EMBO J; 2006 Feb; 25(4):763-73. PubMed ID: 16456545
[TBL] [Abstract][Full Text] [Related]
19. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
Rodríguez-Rodríguez Y; Suárez-Luis I
Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
[TBL] [Abstract][Full Text] [Related]
20. St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.
Nosratabadi R; Rastin M; Sankian M; Haghmorad D; Tabasi N; Zamani S; Aghaee A; Salehipour Z; Mahmoudi M
J Immunotoxicol; 2016 May; 13(3):364-74. PubMed ID: 26634391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
